AI rollout is separating into low-risk uses and testing-gated services
By OnTheRice · Sources and limitations · Report a correction
AI use is becoming more selective. Low-risk help can progress while services that could seriously harm people need stronger testing and human oversight.
Research reference · source time OTR Database Data · not a current quote or execution price · Reference source
Source confidence72% subjective editorial confidence in the synthesis; uncalibrated, not a measured forecast probability
What’s changing?
OTR links a reported cancellation of an autonomous-bus plan with financial-sector AI guidance and work on stronger safeguards. These are different examples, not evidence of one shared fault. Their common point is that a convincing demonstration is not enough for a high-risk service. Over one week, watch project requirements, testing and safer alternatives. A delayed project does not prove every use of the technology has failed. The bus evidence is a media report, and MAS requirements are phased from 2027 and 2028.
Key points
- AI use is becoming more selective. Low-risk help can progress while services that could seriously harm people need stronger testing and human oversight.
- Specify what the product may do, how failure could affect people, when a human takes over and how the controls are tested.
What could change this view?
- Smaller trials may continue and requirements differ by risk. Announcements or delays do not establish actual performance.
Bottom line
For each product, specify permitted actions, failure consequences, human escalation and evidence that the controls work.
Its source facts and prices still need independent checks.
Terms in simple English
These explanations help you read this signal. The saved forecast, prices, deadline and outcome rules stay the same.
- Bullish
- OTR expects the price to rise during the stated time window. This is a forecast, not a promise.
- Bearish
- OTR expects the price to fall during the stated time window. This is a forecast, not a promise.
- Watch or on confirmation
- The signal asks readers to watch for a stated condition. If it also says bullish or bearish, that direction still counts in the recorded outcome check.
- Asset or investible
- Something that can be bought or sold, such as a share, bond, fund, currency or cryptocurrency.
- Share or equity
- A share is a small ownership stake in a company. Its price can rise or fall.
- HIT and MISS
- HIT means the price moved in the recorded direction under that call’s saved rules. MISS means it did not meet those rules. These labels do not measure profit after trading costs.
- Probability
- An estimate of how likely an outcome is. For example, 60% means about six chances in ten, not certainty.
- Guidance or outlook
- Management’s forecast for future sales, profit or other results. It can change.
- SEC or MAS
- SEC is the US Securities and Exchange Commission. MAS is Singapore’s central bank and financial regulator.
- Bayesian framework
- Updating an earlier belief with new evidence. A posterior is the updated estimate; a likelihood ratio compares how evidence fits outcomes. A subjective estimate may have no tested calculation.
- De Finetti framework
- Keeping probability judgements consistent. Related calls may share evidence, so one story must not count as several independent reasons.
- Kolmogorov framework
- Basic probability rules: chances cannot be negative, and separate possible outcomes together total 100%.
- AI or machine learning
- Software learning patterns from examples to perform tasks. Its output can be wrong.
- Deployment
- Making software or a system available for real use. Deployment alone does not prove it works well.
How likely is this call? · Three frameworks
This signal has no investible bullish or bearish call. A market-direction percentage does not apply.
Evidence behind this view
Checks whether separate pieces of evidence support the same view.
research source - complete connector-extracted text read; Singapore section compared with public originals. Public evidence supplies the original dates and boundaries.
What past price moves show
Compares today’s price moves with recorded past patterns.
Not applicable: this is a non-investment synthesis, so we make no asset-price directional call. We do not use price patterns to establish this social or operational outcome.
Evidence against this view
Shows evidence and risks that could challenge this view.
The bus evidence is a media report; smaller trials may continue. MAS requirements are phased from 2027 and 2028.
Why the direction changed
Explains recorded changes from expecting a rise to expecting a fall, or the reverse.
Learning review before publication
The supplied direction was retained: No investible directional call.
The supplied synthesis was retained.
Reason: Retain the researched synthesis and original horizon after six complementary reviews. Overlapping events and qualified past results inform evidence discipline, without establishing calibration or numerical likelihoods.
Lessons considered: Keep the clocks separate; Compare matching quantities; Look for independent evidence; Keep incomplete tests visible; Separate direction from explanation; Use lessons in the next call.
This review belongs to the new draft before publication. Earlier published calls and their original deadlines remain unchanged.
What people say vs the facts
Compares recorded public discussion with checked market facts.
We separate announcements and warnings from observed delivery or measured outcomes. The bus evidence is a media report; smaller trials may continue. MAS requirements are phased from 2027 and 2028.
How past forecasts performed
Shows recorded forecast results and what they can teach us.
No matched past forecast outcome was verified for this specific thesis.
The pre-publication learning review is recorded under “Why the direction changed”, including cases where the supplied direction was retained.
Sources, original wording and price checks
Author-submitted research. The underlying facts and market prices have not been independently verified.
Original research record
We connect the OTR data’s reported cancellation of a planned autonomous-bus deployment with MAS’s risk-proportionate AI guidance and MDDI’s stronger-safeguard work. These are different use cases but share a decision pattern: useful demonstrations are insufficient when a failure can materially harm people. The emerging change is more selective deployment, not a general rejection of AI. Low-risk assistance can advance while high-risk actions need stronger testing and oversight. We think this distinction will shape procurement and public discussion over the coming week. A delayed trial should therefore be analysed through failed requirements and safer alternatives, rather than automatically treated as proof that the entire technology has failed.
For each product, specify permitted actions, failure consequences, human escalation and evidence that the controls work. Watch project scopes, test requirements and official follow-on notices; do not count announcements as proven performance.
The bus evidence is a media report; smaller trials may continue. MAS requirements are phased from 2027 and 2028. For each product, specify permitted actions, failure consequences, human escalation and evidence that the controls work. Watch project scopes, test requirements and official follow-on notices; do not count announcements as proven performance.
For each product, specify permitted actions, failure consequences, human escalation and evidence that the controls work.
Not applicable: this is a non-investment synthesis, so we make no asset-price directional call. Favoured scenario The stated operational development strengthens if its measurable check succeeds; no investment direction applies. Rise scenario Not applicable: this is a non-investment synthesis, so we make no asset-price directional call. We will strengthen the operational thesis if its stated test succeeds. Decline scenario Not applicable: this is a non-investment synthesis, so we make no asset-price directional call. We will weaken the operational thesis if the stated opposing evidence dominates. Neutral Not applicable: this is a non-investment synthesis, so we make no asset-price directional call. An inconclusive check remains unresolved rather than counted as success. Bayesian · what changed the estimate? We revise the explanation when newer evidence changes the proposed cause. Source confidence describes our judgement about support for this synthesis; it is not a price forecast or a tested mathematical result. de Finetti · are the comparisons fair? Related announcements may share one source. Repeated editions do not add independent proof. We test the specific social or practical change described here; investment hit rates do not apply. Kolmogorov · do the numbers agree? No market-price probability applies. Source confidence is a separate judgement, not a bullish, bearish and neutral split.
research source - complete connector-extracted text read; Singapore section compared with public originals. Public evidence supplies the original dates and boundaries.
Not applicable: this is a non-investment synthesis, so we make no asset-price directional call. We do not use price patterns to establish this social or operational outcome.
The bus evidence is a media report; smaller trials may continue. MAS requirements are phased from 2027 and 2028.
N/A - no investment direction is assigned
We separate announcements and warnings from observed delivery or measured outcomes. The bus evidence is a media report; smaller trials may continue. MAS requirements are phased from 2027 and 2028.
No matched past forecast outcome was verified for this specific thesis.
How likely is this call? · Three frameworks
Not applicable: this is a non-investment synthesis, so we make no asset-price directional call. Favoured scenario The stated operational development strengthens if its measurable check succeeds; no investment direction applies. Rise scenario Not applicable: this is a non-investment synthesis, so we make no asset-price directional call. We will strengthen the operational thesis if its stated test succeeds. Decline scenario Not applicable: this is a non-investment synthesis, so we make no asset-price directional call. We will weaken the operational thesis if the stated opposing evidence dominates. Neutral Not applicable: this is a non-investment synthesis, so we make no asset-price directional call. An inconclusive check remains unresolved rather than counted as success. Bayesian · what changed the estimate? We revise the explanation when newer evidence changes the proposed cause. Source confidence describes our judgement about support for this synthesis; it is not a price forecast or a tested mathematical result. de Finetti · are the comparisons fair? Related announcements may share one source. Repeated editions do not add independent proof. We test the specific social or practical change described here; investment hit rates do not apply. Kolmogorov · do the numbers agree? No market-price probability applies. Source confidence is a separate judgement, not a bullish, bearish and neutral split.
Bayesian · what changed the estimate?
We revise the explanation when newer evidence changes the proposed cause. Source confidence describes our judgement about support for this synthesis; it is not a price forecast or a tested mathematical result.
de Finetti · are the comparisons fair?
Related announcements may share one source. Repeated editions do not add independent proof. We test the specific social or practical change described here; investment hit rates do not apply.
Kolmogorov · do the numbers agree?
No market-price probability applies. Source confidence is a separate judgement, not a bullish, bearish and neutral split.
Evidence behind this view
research source - complete connector-extracted text read; Singapore section compared with public originals. Public evidence supplies the original dates and boundaries.
What past price moves show
Not applicable: this is a non-investment synthesis, so we make no asset-price directional call. We do not use price patterns to establish this social or operational outcome.
Evidence against this view
The bus evidence is a media report; smaller trials may continue. MAS requirements are phased from 2027 and 2028.
Why the direction changed
N/A - no investment direction is assigned
What people say vs the facts
We separate announcements and warnings from observed delivery or measured outcomes. The bus evidence is a media report; smaller trials may continue. MAS requirements are phased from 2027 and 2028.
How past forecasts performed
No matched past forecast outcome was verified for this specific thesis.
Forecast prepared Publication time unverified
No explicit investible BULLISH or BEARISH call on this card.
What changed
Recorded public historyWe connect the OTR data’s reported cancellation of a planned autonomous-bus deployment with MAS’s risk-proportionate AI guidance and…
This is the first recorded public view. Further public updates will appear here.
- AI rollout is separating into low-risk uses and testing-gated services
We connect the OTR data’s reported cancellation of a planned autonomous-bus deployment with MAS’s risk-proportionate AI guidance and MDDI’s stronger-safeguard work. These are different use cases but share a decision pattern: useful demonstrations are insufficient when a failure can materially harm people.
Forecast prepared: 13 Oct, 09:27 SGTPublished by OTR: 13 Oct 2026, 09:40 SGT
Why the view changed
This is the first recorded view. Future source-backed updates will appear here.
Evidence, memory & review 3 linked sources
Directional takeaway: N/A
OTR reasoning: We connect the OTR data’s reported cancellation of a planned autonomous-bus deployment with MAS’s risk-proportionate AI guidance and MDDI’s stronger-safeguard work. These are different use cases but share a decision pattern: useful demonstrations are insufficient when a failure can materially harm people. The emerging change is more selective deployment, not a general rejection of AI. Low-risk assistance can advance while high-risk actions need stronger testing and oversight. We think this distinction will shape procurement and public discussion over the coming week. A delayed trial should therefore be analysed through failed requirements and safer alternatives, rather than automatically treated as proof that the entire technology has failed.
Counterpoint: The bus evidence is a media report; smaller trials may continue. MAS requirements are phased from 2027 and 2028. For each product, specify permitted actions, failure consequences, human escalation and evidence that the controls work. Watch project scopes, test requirements and official follow-on notices; do not count announcements as proven performance.
Source trail
- www.mas.gov.sg ↗The research record cites this source; its publication time has not been independently verified.
- www.mddi.gov.sg ↗The research record cites this source; its publication time has not been independently verified.
- www.straitstimes.com ↗The research record cites this source; its publication time has not been independently verified.
Review status: LEARNING REVIEWED WITH DISCLOSED LIMITS
This evidence panel does not assign a score or probability. Any forecast estimate is shown separately with its own source and limitations.
Signals sharing sources
These records are in the same category and cite at least one of the same source documents. Shared evidence is not independent confirmation; each record keeps its own date and conclusion.